AARON FUREY: Open Payments
NPI 1669549432 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$150 in 6 payments from 5 companies in 2025. Trend: 2023 $265 · 2024 $140 · 2025 $150
Food & beverage: $150
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 2 | $45 |
| UCB, Inc. | 1 | $35 |
| ABBVIE INC. | 1 | $26 |
| Lilly USA, LLC | 1 | $24 |
| Janssen Biotech, Inc. | 1 | $21 |
Products named: Bimzelx, COSENTYX, SKYRIZI, TALTZ, TREMFYA.
Industry payments across CA — which companies pay providers there.
